ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Shenzhen Neptunus Bioengineering Files for US Test of TCM
publication date: Jan 18, 2013
Shenzhen Neptunus Bioengineering announced that it has filed an application for a US Phase II clinical trial of Polydatin Injection. Polydatin is a Class I innovative traditional Chinese medicine that aides microcirculation of the blood and is expected to be tested as a treatment for myocardial ischemia, cerebral ischemia, shock and other cardiovascular diseases. More details....
Stock Symbol: (SHE: 000078)
Share this with colleagues:
This article is available for purchase - please click here for details.
Sorry this page is available to subscribers only. If you're not a subscriber why not subscribe today?